URISPAS

Medicinal product

(Invented) name

URISPAS

Active substance (s)

Flavoksatas

Strength

200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD02, Flavoxate

Marketing authorisation holder

Recordati S.p.A., Italija

Date of authorisation

1996-02-15

Date of renewal

2008-06-02

Documents

1176 Pakuotės lapelis 2024 07 19.docx

1176 URISPAS RPP 2024 07 19.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Flavoksatas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
9618	14237	1014237	lizdinė plokštelė	N30		Receptinis	LT/1/96/1176/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-06-02	Perregistruotas
1996-02-15	Registruotas